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It was previously  shown that acquired tolerance  to bovine  serum  albumin 
(BSA),  induced  by neonatal  injection  of rabbits  with  BSA,  was  terminated 
following the injection of certain serum albumins  which cross-react with BSA 
(1). The ability of cross-reacting albumins  to terminate  the tolerant state was 
dependent  on their  serological relation  to BSA.  More  distantly  related  albu- 
mins were more effective in terminating  BSA tolerance  than more closely re- 
lated albumins. It was reasoned from these results that BSA tolerance may also 
be terminated  by the injection of preparations  of BSA that were structurally 
altered but still cross-reacted with native BSA. The present experiments were 
designed to study the immune response in tolerant rabbits  to injections of en- 
zymatically, chemically, and physically altered preparations  of the same pro- 
teins and to study  the effect of injections  of these preparations on the tolerant 
state. 
Materials and Methods 
Antigens.--Both BSA (Lot V08802) and bovine gamma globulin (BGG) (Lot C-904) were 
obtained  from Armour  Pharmaceutical  Company,  Kankakee,  Illinois.  The proteins  were 
trace-labeled with pat (I*) by the method previously described (2). Protein-bound I* activity 
was determined in NaI crystal scintillation counters. The specific activity (counts/microgram 
N) of the I* proteins was determined so that the I* activity could be converted to micrograms 
of protein N. 
Antisera.--Anti-BSA and anti-BGG were obtained  from hyperimmunized  albino rabbits 
prepared  by a series of injections of either BSA or BGG given over a 2 to 4 month period, 
totaling 250 to 300 rag. The last  injection  was given 7 days before bleeding. The sera ob- 
tained  from fifteen to twenty rabbits  were pooled. 
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Alteration  of  Antigens.-- 
(a)  BSA  Complexed  to Anti-BSA.--BSA  was added to hyperimmune rabbit anti-BSA at 
equivalence. The mixture was incubated at 37°C for 30 minutes and then overnight at 0-3°C. 
The precipitate which formed was washed twice with 0.15 •  NaC1 and resuspended in 0.15 
NaC1. 
(b) Pepsln-Degraded BSA.--A  1 per cent BSA solution was partially degraded with pepsin  1 
at pH 2.5 by the technique described by Kaminski and Tanner (3). The pepsin concentration 
was 0.001 rag/rag of protein and the period of incubation was 6 hours at 37°C.  Enzymatic 
degradation was terminated by adjusting the pH to 7.2 with 0.5 ~¢ NaOH. Double diffusion 
in agar between pepsin-degraded  BSA and  anti-native BSA yielded three  to four distinct 
precipitin bands  (4). 
(c) Heat-Denatured BSA.--An  0.5 per cent solution of BSA at pH 7.5 was placed in a boil- 
ing water bath for 1 hour (5). The heat-denatured BSA was purified by repeated precipitation 
at its isoelectric point. 
(d) Acetylated BSA.--Acetylated  BSA (acetyl-BSA) was prepared with acetic anhydride 
according to the procedure described by Olcott and Fraenkel-Conrat  (6). The reaction was 
carried out for 1 hour, at which time about 85 per cent of the amino groups react (5). 
(e) Picrylated BSA.--Picrylated  BSA (picryl-BSA) was prepared with picryl-chloride ac- 
cording to the method described by Benacerraf and Gell (7). The number of pieryl groups per 
molecule of BSA was 27.2 as determined by spectrophotometric analysis, using picryl-epsilon 
aminocaproic acid  ~ as a standard. 
(f) Acetylated-Picrylated  BSA.--Acetylated-pierylated  BSA (acetyl-picryl-BSA) was pre- 
pared by adding picryl-chloride in the manner previously described to acetyl-BSA. The num- 
ber of picryl groups per molecule was 12.2. 
(g) Azoproteins.--Azoproteins  were prepared by the method described by Baker eta/. (8). 
The diazonium derivatives of p-arsanilic and p-sulfanilic acids were prepared in HC1 with 
NaNO2 and  coupled to the proteins at 0°C. The preparations  were dialyzed in phosphate 
buffer,  pH 7.5, ionic strength 0.1, for 12 to 17 days. Equal moles of the two acids were used. 
In the cases where both derivatives were coupled to the same protein preparations,  equal 
molar amounts of each derivative were added so that the total molar quantities were the same 
as when only one of the derivatives was coupled to a protein. The azoproteins contained the 
following number of aso groups per molecule of protein: arsanil-BSA, 5.8;  sulfanil-BSA, 6.9; 
arsanil-sulfanil-BSA, 6.5;  arsanil-BGG,  14.0;  sulfanil-BGG,  18.5;  and  arsanil-sulfanil-BGG, 
16.9. The arsanil-BSA and the arsanil-sulfanil-BSA were also analyzed for arsenic (9). Arsanil- 
BSA contained 11.0 arsenic groups per molecule of protein and arsanil-sulfauil-BSA contained 
3.8 arsenic groups per molecule of protein. Thus,  as previously demonstrated  by Gelewitz, 
Riedeman, and Klotz (10), azoproteins contain more haptenic groups than can be accounted 
for by the azo linkage. 
Rabbits were made tolerant to either BSA or BGG by the method previously described 
(11, 12). Newborn rabbits were given several subcutaneous injections totaling 500 mg of either 
BSA or BGG during the first 5 days after birth. Care was taken to insure an injection of at 
least 100 mg of protein during the first 24 hours following birth.  When the rabbits reached 
maturity (at the 3 to 4 months of age) and prior to their use in the following experiments, they 
were injected intravenously with 20 mg of I*-labeled antigen and  their failure to show an 
immune elimination of the labeled antigen within 2 weeks was used as an index of a tolerant 
state. 
Injection of Native and Altered Protoins.--Both  normal and tolerant rabbits were injected 
1 Worthington Biochemical Corporation,  Freehold, New Jersey. 
2 Kindly supplied by Dr. Baruj Benacerraf. V~LLIA~ O.  WEIGLE  915 
with antigens  either incorporated  in Freund's adjuvant or precipitated  by alum.  Freund's 
adjuvant preparations were composed of nine parts bayol F,  s one part arlaeel C  ~, and ten 
parts 0.15 ~  NaC1 containing the antigen. Except where mentioned, rabbits were injected 
subcutaneously with 2 to 3 ml of adjuvant containing  a total of 25 mg of protein and 0.5 mg 
of mycobacteria (Mycobacterium tuberculosis rat.  hominis). Injections of alum-precipitated 
antigens were given four times per week for 4 weeks (13) and the animals were bled 7 days 
after  the last injection. 
Elimination of I*-BSA from the Circulation.--Mter immunization with one of the altered 
proteins, the tolerant rabbits were bled for antibody and then immediately injected intra- 
venously with 20 mg of an I*-labeled preparation  of the protein used to induce tolerance. 
The sera were analyzed periodically for protein-bound I* activity.  The immune elimination 
of I* activity was used as evidence for the loss of the tolerant state. 
Antibody Ana/yses.mPrecipitating  antibody was measured by the quantitative immuno- 
chemical procedure described by Heidelberger and coworkers (13). In situations where the 
levels of precipitating antibody  were low and could not be measured by this procedure, a quan- 
titative technique (14) utilizing I* antigen, was employed. The ammonium sulfate technique 
of Farr (15) was used to detect either non-precipitating anti-BSA or small amounts of pre- 
cipitating antibody. The ammonium sulfate technique was performed with either 1.0 or 0.1 
ug I*-BSA N and increasing dilutions of antisera, and the results reported as the t~g of I* 
-BSA N  bound to the globulin in 1 ml  of  serum.  Both  non-precipitating  anti-BGG and 
small amounts of precipitating anti-BGG  were detected by the passive cutaneous anaphylaxis 
(PCA) test (16). The degree of cutaneous reaction was recorded as 0 to ++++.  Antisera 
were diluted 1 to 5 and injected in an 0.1 ml volume. One ml of the antigen containing 500 
mg protein per ml was injected in an 0.15 v NaCI solution containing 1 per cent Evans blue. 
Inhibition Studies.--Rabbit  serum containing 2.34 nag anti-BSA N was absorbed at equiva- 
lence with an altered BSA preparation. The remaining antibody to native BSA was determined 
in the presence of an excess of the same altered BSA preparation in an amount equal to 50 
times the amount of BSA necessary to precipitate all of the anti-BSA at equivalence. The ex- 
cess altered BSA was added to the antiserum at 0°C, and the mixture incubated for 30 minutes 
at 37°C and for 1 hour at 0-3°C prior to addition of native BSA. 
RESULTS 
Normal  and  BSA-Tolerant  Rabbits  Injected  with  BSA  Complexed  to  Anti- 
BSA.--Four  normal  and  six  tolerant  rabbits  were  injected  with  complete 
Freund's adjuvant, containing 3.75  mg  of  BSA  complexed  to  anti-BSA at 
equivalence, once a week for 3 weeks and bled 14 days after the last injection. 
The sera of  the four normal rabbits contained 86.6,  34.2,  72.2,  and 86.6  #g 
anti-BSA N  per ml, while none of the sera of  the tolerant rabbits contained 
anti-BSA. Also, the tolerant rabbits failed to show an immune elimination of a 
subsequent injection of I*-BSA. 
Normal and BSA-Tolerant Rabbits Injected with Heat-Denatured BSA.--Five 
normal and five BSA-tolerant rabbits were injected once a  week for 3  weeks 
with Freund's adjuvant, containing 25 mg of heat-denatured BSA, and bled 14 
days after the last injection. The sera of the five normal rabbits contained 367.0, 
s Standard  Off  Company, New Jersey. 
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207.4, 237.0, 258.8, and 169.9/zg anti-heat-denatured BSA N and 170.1, 66.9, 
88.0, 88.5, and 23.7 #g anti-native BSA. The five tolerant rabbits contained 
neither anti-heat-denatured BSA nor anti-native BSA and did not show an 
immune elimination of a subsequent injection of I*-BSA. 
Normal  and  BSA-Tolerant  Rabbits Injected  with  Pepsin-Degraded BSA.-- 
Three normal and six tolerant rabbits were injected with an alum-precipitated 
preparation of pepsin-degraded  BSA.  Sera  of the normal rabbits  contained 
405.8, 190.0, and 172.0/zg of antibody N per ml, which precipitated with pepsin- 
degraded BSA, and 281.8, 86.0, and 145.8/zg of antibody N per ml, which pre- 
cipitated with native BSA. Sera from the tolerant rabbits, however,  did not 
contain antibody which precipitated with either pepsin-degraded BSA or native 
BSA. 
Normal  and BSA-Tolerant Rabbits Injected with Acetyl-BSA.--Four normal 
and seven BSA-tolerant rabbits were injected with alum-precipitated acetyl- 
BSA. Sera of the normal rabbits contained 60.0, 198.5, 47.4, and 73.8/~g anti- 
acetyl-BSA N per ml and 3.1, 9.7, 4.4, and 30.4 #g anti-native BSA N per ml. 
The serum of only one of the tolerant rabbits contained anti-acetyl-BSA (81.0 
~g N per ml) and none of the sera contained anti-native BSA. Six additional 
BSA-tolerant rabbits were injected once  a  week for 3 weeks with complete 
Freund's adjuvant, containing 25 mg of acetyl-BSA, and bled 14 days after the 
last injection. Their sera contained 0, 22.4, 0, 0, 8.6, and 0/~g anti-acetyl-BSA 
N  per ml and no anti-native BSA. The tolerant rabbits injected with either 
alum-precipitated, acetyl-BSA  or  acetyl-BSA  incorporated in  Freund's ad- 
juvant failed to show  an immune elimination of a  subsequent injection of 
I*-BSA. 
Normal  and BSA-Tolerant Rabbits Injected with Picryl-BSA.--Four normal 
and five BSA-tolerant rabbits were injected with an alum-precipitated prepa- 
ration of picryl-BSA. Sera of the normal rabbits contained 87.8, 30.8, 35.6, and 
33.6/zg anti-picryl-BSA N per ml and 9.7, 4.6, 3.4, and 4.8/~g anti-BSA N per 
ml.  Sera  of the five tolerant rabbits  contained neither anti-picryl-BSA nor 
anti-native BSA. The tolerant rabbits also failed to show an immune elimina- 
tion of a subsequent injection of I*-BSA. Also, two normal and five tolerant 
rabbits were injected once a week for 3 weeks with complete Freund's adjuvant 
containing 25 mg picryl-BSA and bled 14 days after the last injection. The sera 
of the two normal rabbits contained 579.5 and 385.0/~g anti-picryl-BSA N per 
ml and 161.0 and 131.0/zg anti-native BSA N per ml, while the sera of the five 
tolerant rabbits contained 0, 0, 0, 176.6, and 120.0 ~g anti-picryl-BSA and no 
anti-native BSA. The tolerant rabbits also failed to show an immune elimina- 
tion of a subsequent injection of I*-BSA. 
BSA-Tolerant  Rabbits Injected  with Picryl-Acetyl-BSA.--Two  of six BSA- 
tolerant rabbits injected once a week for 3 weeks with complete Freund's ad- 
juvant containing 25 mg of acetyl-picryl-BSA lost their tolerant state (Table WILLIAM O. WEIGLE  917 
I). These two rabbits contained small amounts of anti-BSA as indicated by the 
ammonium sulfate precipitation technique and showed an immune elimination 
of a subsequent injection of I*-BSA. 
BSA-Tolerant  Rabbits Injected with Az~-BSA.--Rabbits  were injected once a 
week for 3  weeks with  complete Freund's  adjuvant,  containing  25  mg of an 
azo-BSA, and bled 14 days after the last injection (Tables II, III, and IV). The 
sera were analyzed for antibody to both the native BSA and the azo  groups. 
All sera containing anti-native  BSA were absorbed with native BSA prior to 
analysis for anti-azo-BSA. 
TABLE  I 
Production o/Antibody in BSA-Tolerant Rabbits Injected, with Picryl-Acetyl-BSA 
Rabbit No, 
Antibody to native BSA 
i Precipitating N  Binding~ 
#g 
0  2.4 
o  o 
o  2.0 
o  o 
o  o 
o  o 
Antibody N precipitating with 
Picryl-BSA  Acetyl-BSA 
t*g  ~*g 
42.7  24.4 
0  0 
29.7  19.6 
20.4  12.0 
18.6  14.8 
0  0 
Immune elimi- 
nation of  I*-BSA 
+ 
+ 
:~ Injected once a week for 3 weeks with 25 mg of picryl-acetyl-BSA  in complete Freund's 
adjuvant and bled 14 days after the last injection. 
§ The #g  I*-BSA N  bound by the  globulin fraction  (precipitated  with  50  per  cent 
(NH4)~SO4) of 1 ml of serum. 
The sera of three normal rabbits injected  with arsanil-BSA contained some 
antibody precipitating with both arsanil-BSA and native BSA (Table II). Sera 
of the tolerant rabbits did not contain antibody to native BSA and these rabbits 
did not show immune elimination of a subsequent injection of I*-BSA. The sera 
of three of the four tolerant rabbits did contain small amounts of antibody to 
the arsanil-BSA as detected by the PCA test, but precipitation tests were nega- 
five. 
Sera of the three normal rabbits injected with sulfanil-BSA contained moder- 
ate to high levels of antibody that precipitated with both native and sulfanil- 
BSA (Table III). The sera of three tolerant rabbits injected with sulfanil-BSA 
contained antibody which precipitated with sulfanil-B SA but no antibody which 
precipitated with native BSA. Their sera did contain a  small amount of anti- 
native BSA as detected by the ammonium sulfate technique.  In addition,  the 
three tolerant rabbits showed an immune elimination of a subsequent injection 
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The sera of three normal rabbits injected with arsanil-sulfanil-BSA  contained 
moderate to large amounts of antibody which precipitated with both native 
and arsanil-sulfanil-BSA  (Table IV). The sera of nine tolerant rabbits injected 
with  arsanil-sulfanil-BSA contained moderate  to  large  amounts of  antibody 
TABLE II 
Production of Antibody in Normal and BSA-Tolerant Rabbits Injected~ with 
Arsanil-BSA in Freund's Adjuvant 
Rabbit  No. 
Normal 1 
2 
3 
Tolerant 4 
5 
6 
7 
Antibody to native BSA 
Precipitating  N  Binding][ 
#g 
33.0 
22.2 
3.2 
0  0 
0  0 
0  0 
0  0 
Antibody to arsanil-BSA§ 
Precipitating N  PCA¶ 
17.4 
52.2 
64.5 
0  +++ 
0  ++++ 
0  0 
0  +++ 
Immune elimi- 
nation of I*-BS~ 
m 
~t Injected once a week for 3 weeks with 25 mg of arsanil-BSA in complete Freund's ad- 
juvant and bled 14 days after the last injection. 
§ Absorbed with native BSA prior to determinations. 
[[ The microgram I*-BSA N  bound by the globulin fraction  (precipitated  with 50 per 
cent (NH4)~SO4) of 1 mi of serum. 
¶ Passive cutaneous anaphylaxis. 
TABLE III 
Production of Antibody in Both Normal and BSA-Tolerant Rabbits Injected~ 
with Sulfanil-BSA in Freund's Adjuvant 
Rabbit No. 
Normal 1 
2 
3 
Tolerant 4 
5 
6 
Antibody to native BSA 
Precipitating N 
~g 
312.0 
336.0 
652.8 
mndln~ 
3.3 
2.5 
4.2 
Antibody N 
precipitating with 
sulfanil-BSAl[ 
~g 
158.0 
149.0 
307.4 
226.4 
146.2 
64.8 
Immune elimi- 
nation of I*-BSA 
+ 
+ 
+ 
~t Injected once a week for 3 weeks with 25 mg arsanil-BSA in complete Freund's adjuvant 
and bled 14 days after the last injection. 
§ The microgram I*-BSA N  bound by the globulin fraction  (precipitated  with 50 per 
cent (NH4)iSO4) of 1 ml of serum. 
[] Absorbed with native BSA prior to determinations. BrlL~  O.  WEIGLE  919 
which  precipitated  with  arsanil-sulfanil-BSA and  small  to  large  amounts  of 
antibody which precipitated with native BSA. All of the tolerant rabbits showed 
an immune elimination of a subsequent injection of I*-BSA. 
Six  tolerant  rabbits  were  injected  with alum-precipitated  arsanil-sulfanil- 
BSA. The serum from only one of these rabbits contained antibody which pre- 
TABLE IV 
Production of Antibody in Normal and BSA-Tolerant Rabbits Injected~ with 
Arsanil-Sulfanil-BSA in Freund's Adjuvant 
Rabbit No. 
Normal 1 
2 
3 
Tolerant 4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
Antibody to native BSA 
Precipitating  N 
~g 
556.8 
321.6 
360.0 
302.4 
46.8 
22.8 
146.4 
42.0 
15.0 
331.2 
32.2 
153.6 
Binding§ 
85.8 
21.1 
19.2 
23.8 
15.8 
11.6 
115.5 
17.5 
26.4 
Precipitating  anti- 
body N  to arsanil- 
sulfanil-BSAll 
~g 
208.2 
371.2 
140.4 
206.9 
111.3 
186.8 
313.4 
413.6 
111.0 
242.5 
235.2 
345.3 
Immune elimi- 
nation of I*-BSA 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
:~ Injected once a week for 3 weeks with 25 mg of arsanil-sulfanil-BSA  in complete  Freund's 
adjuvant and bled 14 days after the last injection. 
§ The microgram I*-BSA N  bound by the globulin fraction (precipitated with 50 per 
cent (NH4)2SO4) of 1 ml of serum. 
It Absorbed with native BSA prior to determinations. 
cipitated with native BSA (Table V). Also, this serum was the onlyserum that 
contained  antibody which  precipitated  with  arsanil-sulfanil-BSA.  However, 
the sera of the other five tolerant rabbits contained small amounts of antibody 
to arsanil-sulfanil-BSA as shown by PCA reaction and all six rabbits showed an 
immune elimination of a subsequent injection of I*-BSA. 
BC~Tolerant  Rabbits Injected with Azo-BGG.--All  the  tolerant rabbits  re- 
ceived one injection of complete Freund's adjuvant,  containing 25 mg of an 
azo-BGG, and  were  bled  28  days later.  There  was  no significant  difference 
among  the  results  obtained  with  arsanil-BGG,  sulfanil-BGG,  and  arsanil- 
sulfanil-BGG injected rabbits  (Table VI). The sera of all rabbits  except one 
contained antibody which precipitated with the azo-BGG used for injection. 920  TERMINATION  O~F  IMMUNOLOGICAL  TOLERANCE 
TABLE V 
Production of Antibody in BSA-Tolerant Rabbits Injected~ with Arsanil-Sulfanil-BSA 
Precipitated with Alum 
Rabbit No. 
1 
2 
3 
4 
5 
6 
Antibody to native BSA 
Precipitating N  Binding§ 
gg 
0  0 
0  0 
0  0 
0  0 
16.3  3.6 
0  0 
Antibody to azo groups 
Precipitating N 
~g 
o 
o 
o 
o 
35.5 
o 
PCAH 
+ 
+ 
+++ 
++ 
++++ 
+ 
Immune elimi- 
nation of I*-BSt 
+ 
+ 
+ 
+ 
+ 
+ 
Injected four times per week for 4 weeks with alum-precipitated,  arsanil-sulfanil-BSA. 
§ The microgram  I*-BSA N  bound  by the globulin fraction  (precipitated  with  50 per 
cent (~-I4)2SO4) of 1 ml of serum. 
][ Passive cutaneous anaphylaxis. 
TABLE VI 
Production of Antibody in BGG-Tolerant Rabbits Injezted~ with Azo-BGG in 
Freund's Adju~ant 
Azo-BGG injected 
Arsanil 
Sulfanil 
Arsanil-sulfanil 
Rabbit No. 
Antibody to native BGG 
Preci~tating  PCA§ 
#g 
o  + 
o  ++ 
o 
o 
5.2  +++ 
o  + 
o  + 
o  + 
o  + 
Antibody  (N) 
to azo-BGG 
~g 
117.4 
137.6 
32.4 
29.6 
22.4 
173.6 
7.4 
0 
24.6 
IBll~une 
elimination 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
One injection of 25 mg protein and bled 28 days later. 
§ Passive cutaneous anaphylaxis. 
Only one rabbit (injected with sulfanil-BGG) produced precipitating antibody 
to the native BGG. Most of the rabbits produced antibody to the native BGG 
as detected by the PCA test and all rabbits showed an immune elimination of 
a subsequent injection of I*-BGG. Five BGG-tolerant rabbits injected in a simi- 
lar manner with native BGG failed either to produce circulating anti-BGG or 
to show an immune elimination of a subsequent injection of I*-BGG. V~ILLIA/~ O.  V~EIGLE  921 
Serological  Relationship  between  Altered  and  Anti-Native  Proteins.--The 
serological relationship between the altered BSA preparations and anti-BSA 
was examined by both direct precipitation and inhibition (Table VII). Pooled 
hyperimmune rabbit serum containing 2.34 mg antibody N per ml was used to 
study cross-reactions between altered BSA and anti-native BSA.  With heat- 
denatured,  acetyl-,  and  picryl-BSA  preparations,  the  cross-reactions  were 
greater when carried out with  concentrated antiserum  than with  antiserum 
diluted 1 to 15.  Homologous and  heterologous reactions were  carried out in 
TABLE VII 
Cross-Reactions between Altered BSA Preparations and Anti-Native BSA~ 
Antigen 
Heat-denatured BSA ............... 
Acetyl-BSA  ....................... 
Picryl-BSA  ........................ 
Ar~miI-BSA  ....................... 
Sulfanil-BSA  ....................... 
Arsanil-suifanil-BSA  ................. 
Cross-reactlon 
By direct precipitation 
Antiserum diluted 
(l-15) 
~er~t 
30 
52 
78 
Antiserum conc. 
(0.5 ml) 
per cent 
48 
8O 
75 
80 
84 
By inhibition§ 
per cen~ 
lOO 
lOO 
lOO 
lOO 
lOO 
:~ 2.34 mg antibody N  per ml of pooled hyperimmune serum. 
§ Anti-BSA serum was absorbed at  equivalence with an  altered BSA preparation and 
the remaining anti-BSA determined in the presence of an excess of the same altered prepara- 
tion in a concentration fifty times that necessary to precipitate all of the anti-BSA at equiv- 
alence. 
both concentrated and diluted antiserum. With concentrated antiserum, only 
picryl-BSA gave a 100 per cent cross-reaction by direct precipitation, but all of 
the altered BSA preparations gave a 100 per cent cross-reaction when inhibition 
tests were employed. 
Pooled hyperimmune rabbit serum containing 1.01 mg antibody N  per  ml 
was used to study the cross-reactions between azo-BGG preparations and anti- 
native B GG. As determined by direct precipitation, arsanil-B GG, sutfanil-B GG, 
and arsanil-sulfanil-BGG cross-reacted with rabbit anti-BGG 76,  80,  and 83 
per cent respectively. 
DISCUSSION 
Mature rabbits  made tolerant to BSA by neonatal injections of BSA lost 
their tolerant state following the injection of certain altered BSA preparations. 
BSA which  had diazonium derivatives of both arsanilic aud  sulfanilic acids 922  TERMINATION  OF TMMUNOLOGICAL  TOLERANCE 
coupled to the same molecule was more effective than any other altered prepa- 
rations employed (Table VIII). Tolerance was terminated in all of the rabbits 
injected with Freund's adjuvant containing arsanil-sulfani1-BSA and precipi- 
tating antibody was produced to both the native BSA and the azo groups. 
Arsanil-sulfanil-BSA was also effective in terminating tolerance even when it 
was precipitated by alum. However, picryl-acetyl-BSA, which terminated the 
tolerant state in a  portion of the animals when incorporated into complete 
Freund's adjuvant, had no effect when precipitated  by alum.  BSA  tolerance 
TABLE  VIH 
Antibody Response to Altered BSA in BSA-Tolerant Rabbits$ 
Altered BSA°Iniected 
Heat-denatured. 
Acetyl.. 
Picryl 
Acetyl-picryl 
Arsanil 
Sulfanil 
Arsanil-sulfanil. 
BSA-(native). 
1~O. of 
rabbits 
Anti-native BSA 
Binding  Precipi- 
taring 
+(2)  -- 
+ (3)  - 
+ (9)  + (9) 
Inllnune 
elimina- 
tion of 
I*-BSA 
B 
m 
+ (2) 
+ (3) 
+ (9) 
Anti- 
Altered 
BSA§ 
+ (2) 
+ (2) 
+(4) 
+ (3) 
+(9) 
~; Injected once a week for 3 weeks with 25 mg of antigen in complete Freund's adjuvant 
and bled 14 days after the last injection. 
§ Precipitating antibody. 
Figures in parenthesis show the total number of rabbits which gave positive reactions. 
was also terminated following injections of Freund's adjuvant containing sul- 
fanil-BSA, but only small amounts of binding antibody were produced to  the 
native BSA. The injection of Freund's adjuvant containing native BSA, BSA 
which had been complexed to anti-BSA, or BSA which had been heat-denatured, 
acetylated, picrylated, or coupled to a  diazonium derivative of arsanilic acid 
failed to terminate the tolerant state. Also, only an occasional animal produced 
precipitating  antibody to  these  altered  proteins  and  then  usually in  small 
amounts. 
Other  workers  have  studied  the  antibody response  to  chemically altered 
antigens in rabbits made tolerant to native antigens and observed either little 
or no effect on the tolerant state. In all of these studies the altered antigens were 
injected in a  soluble form rather than incorporated into adjuvant and only a 
single hapten was coupled to an antigen. Denhardt  and Owen  (17)  injected 
soluble sulfanil-BSA into BSA-tolerant rabbits and failed to observe an anti- 
body response. Similarly, Boyden and Sorkin (18) failed to observe an antibody WILLIAM O.  W~IOLS  923 
response in HSA-tolerant rabbits injected with soluble sulfanil-HSA.  On the 
other hand,  Cinader and coworkers  (19, 20)  observed  that the injection of 
soluble  HSA coupled  to  the diazonium derivative of p-aminosulphonic  acid 
(DHSA), into rabbits tolerant to HSA resulted in the production of hemagglu- 
tinating anti-DHSA in three of eight rabbits. However,  only one of the three 
rabbits was shown to give an immune elimination of a subsequent injection of 
I*-HSA.  These data are in sharp contrast to the present data showing  the 
production of small to large amounts of precipitating anti-BSA by BSA-tolerant 
rabbits injected with arsanil-sulfanil-BSA incorporated into complete Freund's 
adjuvant. 
The addition of foreign determinants on BSA probably was more responsible 
for  its  ability  to  terminate  tolerance  than  the  destruction  of  native  de- 
terminants. Although most of the altered BSA preparations used in the above 
experiments  only precipitated a portion of preparations of anti-native BSA, 
all of the altered BSA preparations were able to completely inhibit the precipita- 
tion of anti-native BSA by native BSA. Thus, the altered BSA preparations 
must still contain either all or most of the determinants present on native BSA. 
The degree of cross-reaction  between altered BSA and anti-native BSA as 
revealed by direct precipitation and inhibition, suggests that caution should be 
taken in interpretation of data obtained by studying cross-reactions  by only 
direct precipitation. Based on direct precipitation the cross-reactions between 
altered BSA preparations and anti-native BSA ranged from 30 to 100 per cent 
and depended  on the concentration of antiserum. The per cent of cross-reac- 
reactions was higher with concentrated serum than with diluted serum. A simi- 
lar effect of dilution was observed by Kabat and Schor (21), where more anti- 
body was precipitated by homologous antigen in concentrated antisera than in 
diluted serum when the values  obtained with diluted sera were converted to 
antibody per ml of concentrated sera. Moreover,  the results obtained  in the 
present study by direct precipitation were not meaningful, since all of the al- 
tered BSA preparations showed a  100 per cent cross-reaction  with anti-BSA 
when inhibition studies were employed. Schlamowitz (22) showed that acetyla- 
tion of dog  intestinal phosphatase destroyed its ability to precipitate with 
rabbit antibody, but it still could form soluble complexes with the antibody. 
Similarly, Nisonoff and Pressman (23) found that acetylation of rabbit anti- 
BSA destroyed its ability to precipitate with BSA, but that the acetylated 
antibody still combined with BSA to form soluble complexes. They attributed 
this result to electrostatic repulsion effects among the antibody molecules. 
The ability of injections  of a heterologous serum albumin to terminate the 
tolerant state of BSA-tolerant rabbits appeared to depend on the serological 
relationship between that albumin and BSA (1). On the other hand, there was 
no evidence  that the ability of injections  of an altered BSA preparation to 
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the altered BSA and native BSA. However, such a  dependence might exist 
which could not be shown by the serological techniques employed. 
A difference in the sites on the protein molecule to which the haptens are 
coupled may explain why arsanil-sulfanil-BSA is more effective in terminating 
BSA tolerance than picryl-acetyl-BSA. Picryl and acetyl groups are coupled 
mainly to the epsilon amino groups of lysine, which are believed not to be in- 
volved in antigenicity, while at least a portion of the diazonium derivatives are 
coupled to tyrosine, which is thought to contribute to the antigenicity of pro- 
teins. 
The results summarized in Table VIII indicate that injection of BSA mole- 
cules containing two different haptens in combination was more effective in 
terminating the tolerant state than the injection of BSA molecules containing 
only one of the two haptens. However, quite different results were obtained 
when azo-BGG preparations were injected into BGG-tolerant rabbits.  Injec- 
tion of BGG preparations  coupled to a  single diazonium derivative was as 
effective in terminating BGG tolerance as injection of BGG coupled to two 
different derivatives. The discrepancy between these two systems may be ex- 
plained by the antigenic heterogenicity of gamma globulin (24,  25).  Certain 
determinants may be present on such a  small proportion of the native BGG 
molecules that their concentration is too low for the rabbit to develop tolerance 
to them. That tolerance need not be established to every determinant on a 
protein to render that protein non-antigenic was shown by the failure of sheep 
serum albumin to elicit an immune response in BSA-tolerant rabbits (1). Thus, 
the addition of a single hapten to BGG may be sufficient to permit some BGG 
molecules to be recognized as foreign in the BGG-tolerant rabbit. Whether the 
presence of two or more different, foreign determinants on a substance is neces- 
sary to permit it to be recognized as foreign will have to await further experi- 
mentation  employing  altered  proteins  in  which  the  exact  nature  of  the 
alteration is known. However, it appears reasonable to assume that the area of 
the surface of a protein molecule, responsible for its being recognized as foreign, 
includes more than one single determinant. 
The termination of tolerance by injection of related antigens can be explained 
if it is accepted that two steps are involved in an antibody response. The first 
step, recognition, would be selective in that only genetically appropriate cells 
could respond and this recognition apparently involves multiple determinant 
groups on the antigen. The second step, antibody production, would involve the 
synthesis of antibody to individual determinant groups on the molecule once 
it has been recognized as foreign. Cells or subcellular units capable of recog- 
nizing BSA as foreign would be absent in the BSA tolerant rabbit, but cells or 
subcellular units capable of recognizing certain altered BSA molecules would be 
present. Once an altered or cross-reacting protein is recognized as foreign, it 
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antibody may be made to both foreign and previously tolerated determinants. 
Altered or cross-reacting substances  that are not recognized as foreign may be 
unable to confront the antibody-producing sites and thus antibody could not 
be made to either tolerated or foreign determinants. 
The termination of acquired  tolerance is not readily explained by the clonal 
selection  theory of antibody production. This theory suggests  that acquired 
tolerance results from the destruction or inhibition of cells which are destined 
to make antibody to a specific antigen (26). The ability of the injection of al- 
tered or cross-reacting  antigens to  cause a termination of acquired tolerance 
suggests that there are cells in the tolerant rabbit that are capable of producing 
antibody to the tolerated antigen if properly stimulated. That such cells can 
be stimulated has been demonstrated with the fluorescent  antibody technique 
(27). However, the present results can be explained by a selection theory (possi- 
bly clonal) where selection would take place at the recognition level rather than 
at the antibody production level. Thus, any potential antibody-producing cell 
would be capable of making antibody to any antigen (even self), if that antigen 
were first recognized as foreign. To insure a total tolerance,  contact with the 
antigen in early life would have to destroy only the cells or subcellular  units 
responsible for recognition. By injecting related antigens which are recognized 
as foreign, both related and unrelated determinants may be permitted to con- 
front the antibody-producing sites  of the previously tolerant animals where 
antibody may be made to both the unrelated and the related determinants. 
The component that limits the antibody response may be the recognition unit 
rather than the antibody-producing site.  The recognition  phase may involve 
either preparation of the antigen to permit it to enter the antibody-producing 
site or transfer of information to the antibody-producing site. The recognition 
units might be contained in a cell type different from the cells involved in anti- 
body synthesis, in a cell type the same as the cells involved in antibody syn- 
thesis but possessing a different  function, or in the same cells that are involved in 
antibody  production. The above postulation is partially based on the assumption 
that a single cell is potentially capable  of making antibody to many different 
antigenic determinants. However, all cells would not be expected to respond in 
the same manner to a  given determinant. The antibody-producing cells may 
vary widely in the quality and quantity of antibody they produce to the same 
antigenic determinant, thus accounting for the heterogeneity of antibody. 
The present results can be discussed in relation to autoimmune diseases if it is 
accepted that the tolerance  induced in neonatal rabbits to heterologous pro- 
teins is similar to the tolerance of normal rabbits to their own body constituents. 
Thus, BSA, which is heterologous to the normal rabbit, may be considered to 
be autologous to the BSA-tolerant rabbit. The termination of tolerance to BSA 
then may involve mechanisms  similar to those involved  in autoimmunity. If 
these assumptions  are correct,  the termination of acquired  tolerance  may be 926  TERMINATION  OF vM'M'U'NOLOGICAL  TOLERANCE 
viewed as an experimental model of autoimmunity. Accordingly, an individual 
could either contact a  substance related to a  constituent of the body, or as a 
result of trauma, inflammation, etc., a  constituent of the body could become 
altered. In either case, an autoimmune response might result with accompany- 
ing autoantibodies. 
SUMMARy 
Acquired tolerance  to BSA in  rabbits  was terminated following  the injection 
of certain  preparations of altered  BSA. Injections  of Freund's adjuvant con- 
taining  BSA complexed to anti-BSA, heat-denatured BSA, acetyl-BSA, picryl- 
BSA, or arsanil-BSA failed  to terminatc the tolerant  state.  Except in an oc- 
casional tolerant  rabbit,  injections  of these  preparations failed  to cause the 
production of  precipitating  antibody to the altered  preparation.  Similar  results 
were obtained following  injections  of alum-precipitated  preparations  of pepsin- 
degraded BSA, acetyl-BSA, and picryl-BSA. Injections  of Freund's adjuvant 
containing  sulfanil-BSA terminated the tolerant  state,  but only small amounts 
of non-precipitating  anti-BSA were produced. Injections  of Freund's adjuvant 
containing picryl-acetyl-BSA tcrminatcd the tolerant  state  in two of six rab- 
bits,  but again, only small amounts of non-precipitating  and-BSA were pro- 
duced. Injections  of an alum-precipitated preparation of picryl-acetyl-BSA 
failed  to terminate the tolerant  state.  On the other  hand, injections  of  Freund's 
adjuvant containing arsanll-sulfanfl-BSA  terminated  the tolerant state in 
eleven of eleven  rabbits  and caused the production of precipitating  anti-BSA 
in all  nine of the rabbits  tested.  The tolerant  state  was terminated also  in six 
of  six  rabbits  injected  with an alum-precipitated  preparation of  arsanil-sulfanll- 
BSA. Only one of these  rabbits  produced precipitating  anti-BSA. In addition, 
the injection  of BGG-tolerant rabbits with arsanil-BGG,  sulfanll-BGG, or 
arsanll-sulfanil-BGG  terminated  the  tolerant  state.  These  results  were  dis- 
cussed in relation to both the clonal selection theory of antibody production 
and autoimmunity. 
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Miss Kaete Lorenz for thdr competent technical assistance. 
BIBLIOGRAPHY 
I. Weigle, W. 0., The immune response of rabbits tolerant to bovine serum albumin 
to the injection of other heterologous  serum albumins, J..Exp.  Med., 1951, 
114, 111. 
2.  Weigle,  W.  0., and Dixon, F.  J., The antibody response  of lymph node cells 
transferred to tolerant recipients,  J. Imr,  mnol., 1959, 89., 516. 
3.  Kaminski, M.,  and  Tanner,  C.  E.,  Etude  comparative par  electrophorese en 
gelose  et immunoelectrophorese de la degradation de la serumalbumine hu- WILLIAM O.  FV-EIGLE  927 
maine par la pepsin,  la trypsine et la chymotrypsine, Biochim. et Biophysica. 
Acta, 1959, 33, 10. 
4.  Weigle, W. O., Immunochemical  properties of the cross-reactions  between anti- 
BSA and heterologous albumins,  J. Immunol.,  1961, 87, 599. 
5.  Ehrenpreis, S., Maurer, P. H., and Sri Ram, J., Modified bovine serum albumin. 
I. Preparation and physiochemical studies of some derivatives, Arch. Biochem. 
and Biophysics., 1957, 67, 178. 
6.  Olcott, H.  S.,  and  Fraenkel-Conrat, H.,  Specific group reagents for proteins, 
Chem. Rev., 1947, 41, 151. 
7.  Benacerraf, B., and Gell, P. G. H., Studies on hypersensitivity. I. Delayed and 
Arthus-type skin reactivity to protein conjugates in guinea pigs, Immunology, 
1959, 9., 53. 
8.  Baker, M. C., Campbell, D. H., Epstein, S. I., and Singer, S. J., Physical chemi- 
cal  studies of soluble  antigen-antibody complexes. VII.  Thermodynamics of 
the reaction between benzenearsonic acid-azo-bovine serum albumin and rabbit 
antibodies to benzenearsonic  acid, Y. Am. Chem. Soc., 1956, 78, 312. 
9.  Kagaku, S., Colorimetric  determination of minute amounts of phosphorus and 
arsenic  in  copper metal by fractional extraction method, Bunseki  Kagaku, 
1956, 5, 395. 
10.  Gelewitz, E. W., Riedeman, W. L., and Klotz, I. M., Some quantitative aspects 
of the reaction of diazonium  compounds  with serum albumin,  Arch. Bio,hem. 
and Biophysics, 1954, 53, 411. 
11.  Weigle,  W.  O.,  and  Dixon,  F.  J.,  Elimination of heterologous  proteins from 
blood  of normal, x-radiated and  tolerant rabbits, Proc. Soc. Exp.  Biol.  and 
Mat., 1958, 98, 213. 
12.  Weigle,  W.  O.,  and  Dixon,  F.  J.,  Immunologic  unresponsiveness  to  protein 
antigens, in Mechanisms of Hypersensitivity, (J. H. Schaffer, G. A. LoGrippo, 
and M.  W.  Chase,  editors), Boston, Little, Brown  & Company,  1959, 529. 
13.  Kabat, E. A., and Mayer, M. M., Experimental immunoehemistry, 2nd edition, 
Springfield, Illinois, Charles C. Thomas, 1961. 
14.  Talmage,  D.  W.,  and  Maurer,  P.  H.,  I18t-iabelled antigen precipitation as  a 
measure  of quantity and quality of antibody, J. Infect. Dis.,  1953, 99., 288. 
15.  Farr, R. S., A quantitative immunochemical measure of the primary interaction 
between I*BSA and antibody, J. Infect. Dis., 1958, 103, 239. 
16.  Ovary, Z., Immediate reactions in the skin  of experimental animals  provoked 
by antibody-antigen interaction, Progr. Allergy, 1958, 5, 459. 
17.  Denhardt, D. T., and Owen, R.  D., The resistance  of the tolerant state to x- 
radiation, Transplant. Bull.,  1960, 7, 394. 
18.  Boyden, S. V., and Sorkin,  E., Effect of neonatal injections of protein on the 
immune  response  to  protein-hapten  complexes,  Immunology,  1962, 5,  370. 
19.  Cinader, B., and Dubert, J. M., Acquired immune tolerance to human albumin 
and the response  to subsequent injections  of diazo human albumin, Brit.  J. 
Exp. Path., 1955, 36, 515. 
20.  Cinader,  B., and Pearce, J. H., The specificity of acquired immunological toler- 
ance to azo proteins, Brit. J. Exp. Path., 1958, 34, 8. 928  TERMINATION OF  ~K~UNOLOGICA][, TOLERANCE 
21.  Kabat, E. A., and Schor, J. M., cited in Experimental Immunochemistry, 2nd 
edition, Springfield, Illinois, Charles C. Thomas, 1961. 
22.  Schlamowitz, M., Effects of cysteine and acetic anhydride on the antigenic and 
catalytic sites of dog intestinal alkaline phosphatase, J. Immunol., 1959, 83, 29. 
23. Nisonoff,  A.,  and Pressman, D.,  Studies on the combining  site of anti-p-azo- 
benzoate antibody. Loss of precipitating and binding capacities  through dif- 
ferent mechanisms on acetylation, ]. Immunol., 1959, 83, 138. 
24.  Korngold, L., and van Loeuwen,  G., The use of cross-reacting  antiserums for 
the study of antigenic heterogeneity of mammalian gamma-2  globulins,  In- 
ternat. Arch. Allergy and Appl. Immunol., 1961, 19, 271. 
25. Augustin,  R.,  and IIayward, B. J., Immunochemical studies of human serum 
proteins. Antigenic  inhomogeneities  of the gamma globulins,  their subunits 
and  number  of determinents and  their  relation  to  a  Waldenstrom  macro- 
globulin, Immunology, 1961, 4, 450. 
26.  Burnet, F. M., A modification  of Jerne's theory of antibody production using 
the concept of clonal selection, Australian Y. Sc., 1957, 20, 67. 
27.  Cochrane, C. G., and Weigle, W. O., unpublished observations. 